In the world of Oncology, very few have been able to reach the heights attained by Mikhail Blagosklonny. He is an Oncology professor and scientist at the Rosewell Park Cancer Institute in Buffalo, New York and concentrates his study on ageing and cancer. Mikhail’s contribution towards the field of Oncology is immense and unparalleled.He has worked in different places, conducting a lot of research and studies on cancer and therapies. This has enabled Mikhail Blagosklonny to gain a lot of skills hence making him an exceptional professor.Aside from that, he also doubles as the Editor- in-Chief of the Oncotarget publication. This is a weekly medical journal whose primary focus is on ageing. It was launched in 2010. Additionally, Mikhail is the associate editor of therapy and cancer biology. He is also on the editorial board of Cell Differentiation and Death.
Blagosklonny’s Career and Education Background spans across many years of extensive research and study. He holds an MD in Internal Medicine as well as a PhD in Cardiology and Experimental Medicine from the First Pavlov State Medical University of St. Petersburg.He has previously worked with New York Medical College as an associate professor of Medicine and Ordway Research Institute as a senior scientist. In 2009 however, Mikhail became an Oncology Professor at the Roswell Park Cancer Institute.Most of Mikhail’s research focuses on cancer and most importantly anti-aging drugs and cancer therapies. Mikhail is also well known for Rapamycin, a cancer drug that he greatly advocates for. This is because it is said to increase the lifespan of a human being.His extensive research on the drug Rapamycin has included clinical investigations, molecular biology, and cellular biology. Most of his studies are guided by the theory of ageing hyperfunction.
All through his work, his passion for a disease free community stands out. His drive to achieve this is what made him venture into Oncology and research.Mikhail Blagosklonny does not only work with his patients to help them recover, he also engages with other cancer experts to find solutions to the cancer menace. He believes that by putting their brains together, they are able to devolve complex situations and find solutions.Through this, he hopes he will be able to find the cure to cancer. It is clearly bearing fruits as he has made very many strides.Through his publication Oncotarget, Mikhail Blagosklonny has documented his strides and interactions with his peers. This is captured in the peer review segment of the publication.His collaborations with them on different cancer findings has helped many patients experience better treatment.His target for the Oncotarget is to bring many experts and enabling them to work together in the different research situations and subjects.The publication has now seen more and more peers join his team to study how to beat cancer. Not only Oncologists but also neurologists, endocrinologists and other doctors have joined in thanks to the work of Mikhail Blagosklonny and Oncotarget.Medicine students have also been incorporated to learn these new techniques as taught by Mikhail Blagosklonny and make use of it in their practice. They are also able to consult Mikhail Blagosklonny and his team as often as possible.